Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or ObesityPatricia J. Rodriguez, Ezekiel Emanuel, Vincent Zhang et al.|JAMA Network Open|2025Cited by 257
Early MMR Vaccine Adoption During the 2025 Texas Measles OutbreakBrianna M Goodwin Cartwright, Nicholas L Stucky, Karen M. Gilbert et al.|JAMA Network Open|2025Cited by 2
HPR108 Trends in the Prescribing and Dispensing of GLP-1 Anti-Obesity Medications Among U.S. Adults with Cardiovascular Disease and Overweight or Obesity, 2021-2024Duy Do, N. Stucky, Karthik Murugiah et al.|Value in Health|2025Cited by 0
EPH49 Characteristics and Adherence of Patients Initiating Injectable Cabotegravir for HIV Treatment or PreventionDuy Do, N. Stucky, B Cartwright et al.|Value in Health|2025Cited by 0